Lineage Cell Therapeutics (LCTX) Capital Leases (2014 - 2026)
Lineage Cell Therapeutics posted quarterly Capital Leases of $22000.0 for Q1 2026, down 56.86% year-on-year from $51000.0 in Q1 2025, and down 31.25% on a QoQ basis from $32000.0 in Q4 2025.
Lineage Cell Therapeutics (LCTX) has 13 years of Capital Leases data on file, last reported at $22000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Leases fell 56.86% year-over-year to $22000.0; the trailing twelve-month figure through Mar 2026 stood at $22000.0 (down 56.86% YoY), and the FY2025 full-year result was $32000.0, down 52.24% from the prior year.
- Capital Leases for Q1 2026 stood at $22000.0, down from $32000.0 in the prior quarter.
- Across five years, Capital Leases topped out at $133000.0 in Q1 2023 and bottomed at $16000.0 in Q3 2022.
- The 5-year median for Capital Leases is $67000.0 (2024), against an average of $62705.9.
- The widest annual swing landed in 2023, when Capital Leases jumped 506.25%; it then sank 56.86% in 2026.
- A 5-year view of Capital Leases shows it stood at $84000.0 in 2022, then grew by 8.33% to $91000.0 in 2023, then decreased by 26.37% to $67000.0 in 2024, then slumped by 52.24% to $32000.0 in 2025, then tumbled by 31.25% to $22000.0 in 2026.
- The last three Capital Leases figures came in at $22000.0 (Q1 2026), $32000.0 (Q4 2025), and $40000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Lineage Cell Therapeutics | 325.89 Mn | 261.99 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Sep 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 48,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Dec 31, 2024 | 67,000.00 |
| Sep 30, 2024 | 80,000.00 |
| Jun 30, 2024 | 68,000.00 |
| Mar 31, 2024 | 79,000.00 |
| Dec 31, 2023 | 91,000.00 |
| Sep 30, 2023 | 97,000.00 |
| Jun 30, 2023 | 113,000.00 |
| Mar 31, 2023 | 133,000.00 |
| Dec 31, 2022 | 84,000.00 |
| Sep 30, 2022 | 16,000.00 |
| Jun 30, 2022 | 19,000.00 |
| Mar 31, 2022 | 26,000.00 |
| Dec 31, 2021 | 30,000.00 |
| Sep 30, 2021 | 12,000.00 |
| Jun 30, 2021 | 16,000.00 |
| Mar 31, 2021 | 26,000.00 |
| Dec 31, 2020 | 26,000.00 |
| Sep 30, 2020 | 29,000.00 |
| Jun 30, 2020 | 62,000.00 |
| Mar 31, 2020 | 66,000.00 |
| Dec 31, 2019 | 77,000.00 |
| Sep 30, 2019 | 87,000.00 |
| Jun 30, 2019 | 93,000.00 |
| Mar 31, 2019 | 103,000.00 |
| Dec 31, 2018 | 104,000.00 |
| Sep 30, 2018 | 110,000.00 |
| Jun 30, 2018 | 116,000.00 |
| Mar 31, 2018 | 122,000.00 |
| Dec 31, 2017 | 132,000.00 |
| Dec 31, 2016 | 310,000.00 |
| Sep 30, 2016 | 89,000.00 |
| Jun 30, 2016 | 122,000.00 |
| Mar 31, 2016 | 32,000.00 |
| Dec 31, 2015 | 26,000.00 |
| Dec 31, 2014 | 115,000.00 |
| Jun 30, 2014 | 115,000.00 |